Onconova Therapeutics, Inc. (37)

Browse by Contract Category

Contracts

Amendment to Employment Agreement, dated as of March 18, 2021, by and between Onconova Therapeutics, Inc. and Steven M. Fruchtman, M.D (Filed With SEC on March 18, 2021)
Underwriting Agreement, dated February 10, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 12, 2021)
Description of the Company's Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 27, 2020)
Distribution, License and Supply Agreement, dated as of December 18, 2019, by and between Onconova Therapeutics, Inc. and Specialised Therapeutics Asia Pte. Ltd (Filed With SEC on December 19, 2019)
License and Collaboration Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc (Filed With SEC on August 14, 2019)
Form of Purchase Agreement, dated as of January 7, 2021, by and among Onconova Therapeutics, Inc. and the investors party thereto (Filed With SEC on January 8, 2021)
Form of Stock Appreciation Right Award Agreement (for Non-Employee Directors) (Filed With SEC on November 16, 2020)
Form of Performance Stock Unit Award Agreement (Filed With SEC on July 10, 2020)
Form of Stock Appreciation Right Award Agreement (Filed With SEC on July 10, 2020)
Form of Securities Purchase Agreement, dated as of December 31, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on January 3, 2020)
Form of Placement Agent Warrant (Filed With SEC on January 3, 2020)
Form of Securities Purchase Agreement, dated as of December 17, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 19, 2019)
Form of Investor Warrant (Filed With SEC on December 19, 2019)
Form of Placement Agent Warrant (Filed With SEC on December 19, 2019)
Form of Investor Warrant (Filed With SEC on December 10, 2019)
Form of Placement Agent Warrant (Filed With SEC on December 10, 2019)
Form of Securities Purchase Agreement, dated as of December 6, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 10, 2019)
Form of Securities Purchase Agreement, dated as of November 21, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on November 26, 2019)
Form of Placement Agent Warrant (Filed With SEC on November 26, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 26, 2019)
Form of Common Warrant (Filed With SEC on November 26, 2019)
Distribution, License and Supply Agreement, dated as of November 20, 2019, by and between Onconova Therapeutics, Inc. and Knight Therapeutics Inc (Filed With SEC on November 21, 2019)
SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 14, 2019)
Form of Placement Agent Warrant (Filed With SEC on November 14, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 14, 2019)
Form of Warrant (Filed With SEC on November 14, 2019)
Form of Underwriter Warrant (Filed With SEC on November 12, 2019)
Form of Pre-Funded Warrant (Filed With SEC on November 12, 2019)
Form of Warrant (Filed With SEC on November 12, 2019)
Form of Underwriting Agreement (Filed With SEC on November 12, 2019)
Form of Amendment to Warrant, dated as of September 23, 2019 (Filed With SEC on November 12, 2019)
Form of Securities Purchase Agreement, dated as of September 23, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on September 25, 2019)
Form of Placement Agent Warrant (Filed With SEC on September 25, 2019)
Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and Abundant New Investments Ltd (Filed With SEC on August 14, 2019)
Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc (Filed With SEC on August 14, 2019)
Sales Agreement, dated May 17, 2019, by and between Onconova Therapeutics, Inc. and Roth Capital Partners, LLC (Filed With SEC on May 17, 2019)
Separation and Release Agreement, effective as of January 15, 2019, by and between Onconova Therapeutics, Inc. and Ramesh Kumar, Ph.D (Filed With SEC on January 15, 2019)